SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-025902
Filing Date
2023-04-03
Accepted
2023-04-03 09:21:21
Documents
15
Period of Report
2023-03-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea176317-8k_dominari.htm   iXBRL 8-K 30970
2 EMPLOYMENT AGREEMENT, MADE AND ENTERED INTO AS OF MARCH 29, 2023, BY AND BETWEEN ea176317ex10-1_dominari.htm EX-10.1 73479
3 PRESS RELEASE ANNOUNCING GEORGE WAY AS THE CHIEF FINANCIAL OFFICER OF DOMINARI H ea176317ex99-1_dominari.htm EX-99.1 9946
4 GRAPHIC ex99-1_001.jpg GRAPHIC 8968
  Complete submission text file 0001213900-23-025902.txt   324141

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE bp2a-20230329.xsd EX-101.SCH 3239
6 XBRL LABEL FILE bp2a-20230329_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE bp2a-20230329_pre.xml EX-101.PRE 22367
9 EXTRACTED XBRL INSTANCE DOCUMENT ea176317-8k_dominari_htm.xml XML 3602
Mailing Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020
Business Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020 347-321-7646
Dominari Holdings Inc. (Filer) CIK: 0000012239 (see all company filings)

IRS No.: 520849320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-05576 | Film No.: 23790918
SIC: 2834 Pharmaceutical Preparations